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Abstract: Optic neuropathy refers to disorders involving the optic nerve (ON). Any damage to 
ON or ON-deriving neurons, the retinal ganglion cells (RGCs), may lead to the breakdown of 
the optical signal transmission from the eye to the brain, thus resulting in a partial or complete 
vision loss. The causes of optic neuropathy include trauma, ischemia, inflammation, compression, 
infiltration, and mitochondrial damages. ON injuries include primary and secondary injuries. 
During these injury phases, various factors orchestrate injured axons to die back and become 
unable to regenerate, and these factors could be divided into two categories: extrinsic and intrinsic. 
Extrinsic inhibitory factors refer to the environmental conditions that influence the regeneration 
of injured axons. The presence of myelin inhibitors and glial scar, lack of neurotrophic factors, 
and inflammation mediated by injury are regarded as these extrinsic factors. Extrinsic factors 
need to trigger the intracellular signals to exert inhibitory effect. Proper regulation of these 
intracellular signals has been shown to be beneficial to ON regeneration. Intrinsic factors of 
RGCs are the pivotal reasons that inhibit ON regeneration and are closely linked with extrinsic 
factors. Intracellular cyclic adenosine monophosphate (cAMP) and calcium levels affect axon 
guidance and growth cone response to guidance molecules. Many genes, such as Bcl-2, PTEN, 
and mTOR, are crucial in cell proliferation, axon guidance, and growth during development, and 
play important roles in the regeneration and extension of RGC axons. With transgenic mice and 
related gene regulations, robust regeneration of RGC axons has been observed after ON injury 
in laboratories. Although various means of experimental treatments such as cell transplantation 
and gene therapy have achieved significant progress in neuronal survival, axonal regeneration, 
and restoration of the visual function after ON injury, many unresolved scientific problems 
still exist for their clinical applications. Therefore, we still need to overcome hurdles before 
developing effective therapy to treat optic neuropathy diseases in patients.
Keywords: retinal ganglion cells, optic nerve injury, neuronal survival, axonal regeneration, 
vision restoration
Optic neuropathy refers to disorders involving the optic nerve (ON). Because ON 
transmits optical signals from the eye to the brain, any damage to ON or ON-deriving 
neurons, the retinal ganglion cells (RGCs), may lead to the breakdown of this transmis-
sion, thus resulting in loss of visual field and eventually partial or complete vision loss. 
The causes of optic neuropathy include trauma, ischemia, inflammation, compression, 
infiltration, and mitochondrial damages (nutritional, toxic, and hereditary).
Primary ON injuries, such as mechanical perturbance, ischemia, hypoxia, and 
inflammation, lead to direct axonal damage, while secondary injury may exacerbate 
the damage by complicated mechanisms including immune reaction, oxidative free 
radicals, and excitatory cellular toxicity. During these injury phases, various factors 
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orchestrate injured axons to die back and become unable 
to regenerate, and these factors could be divided into two 
categories: extrinsic and intrinsic.
Extrinsic inhibitory factors refer to all conditions in the 
ON but outside RGCs, namely the environmental conditions 
that influence the regeneration of injured axons. Lack of 
neurotrophic factors, the presence of myelin inhibitors, and 
glial scar composed of chondroitin sulfate proteoglycans 
(CSPGs) are being investigated. Inflammation mediated by 
injury including immune cell infiltrations is also included as 
an extrinsic factor, but is more complicated. Intrinsic factors 
of RGCs are the pivotal reasons that inhibit ON regeneration 
and are closely linked with extrinsic factors. Intracellular 
cyclic adenosine monophosphate (cAMP) and calcium levels 
affect axon guidance and growth cone response to guidance 
molecules. Extrinsic factors need to trigger the intracellular 
signals to exert inhibitory effect. Guanosine triphosphatase 
(GTPase) and Ras homolog gene family member A (RhoA) 
– a small GTPase, involved signals are associated with 
myelin-associated glycoprotein (MAG) and other myelin-
derived inhibitory factors in axonal regeneration. Proper 
regulation of these intracellular signals has been shown to be 
beneficial to ON regeneration. Recent research works found 
that many genes, usually playing roles in cell proliferation, 
axon guidance or growth during development, were down-
regulated after development and played important roles in 
the regeneration and extension of RGC axons. These genes 
include B-cell lymphoma 2 (Bcl-2), phosphatase and tensin 
homolog (PTEN), and the mammalian target of rapamycin 
(mTOR). With transgenic mice and related gene regulations, 
robust regeneration of RGC axons has been observed after 
ON injury in laboratories.1–3
Although various means of experimental treatments such 
as cell transplantation and gene therapy have achieved sig-
nificant progress in neuronal survival, axonal regeneration, 
and restoration of the visual function after ON injury, many 
unresolved scientific problems still exist for their clinical 
applications. Therefore, more time is needed before the aim 
of clinical applications of these effective therapeutic methods 
is achieved.
Experimental neurorestorative 
studies
Factors and medicine
Anti-myelin-derived inhibitors
The use of anti-myelin-derived inhibitors is an important 
strategy for ON regeneration. Techniques include antibod-
ies, antisense oligonucleotide, gene knockout, interruption 
of ligand-receptor combination, and blockage of associated 
signal pathway.
Nogo-A is one of the most potent oligodendrocyte-derived 
inhibitors for axonal regrowth in injured adult cerebral ner-
vous system (CNS). Using an anti-Nogo-A antibody or by 
expressing a dominant-negative form of the Nogo receptor 
(NgR) in RGCs can block the activity of Nogo. However, Cui 
et al found that application of IN-1, an antibody against Nogo, 
alone failed to enhance regeneration of transected RGC axons 
in a peripheral nerve (PN) graft. IN-1 hybridoma cells also 
failed to significantly promote crushed ON axons to reenter 
the distal part of the ON. However, a combined application 
of IN-1 and ciliary neurotrophic factor (CNTF) had a syn-
ergistic effect in ON crush paradigms, suggesting that the 
action of IN-1 antibodies in promoting axonal regeneration 
in the CNS could be more effective when coupled with other 
appropriate factors.4 Su et al demonstrated that Nogo-A-
deficient mice showed significantly longer axon regrowth 
than control, according to growth-associated protein-43 
immunohistochemistry and Nogo-A/B/C knockout resulted 
in more active regeneration of RGC axons, and suggested 
Nogo knockout could be an effective way to eliminate this 
inhibition and accelerate axonal regeneration.5 Knockout of 
the Nogo-66 receptor enhanced regeneration after ON crush.6
Counteracting the NgR enhances ON regeneration if 
RGCs are in an active growth state, but when the growth 
program of RGCs is not activated, the negative form of the 
NgR would not have any beneficial effect.7 Chen inhibited 
NgR by RNA interference and recruited exogenous trophic 
support by the zymosan intravitreal injection and found 
that either approach can stimulate ON axonal regrowth but 
regenerating axons can grow longer and extend further when 
both methods were combined.8 When associated with NgR, 
the transmembrane receptor p75NTR signals the collapse of 
growth cones. Ahmed et al showed that the in vivo ON regen-
eration correlates with Schwann cell-derived factor-induced 
cleavage of NgR and Nogo-A, and inactivation of p75NTR 
signaling by the induction of regulated intramembranous 
proteolysis and the release of both extracellular (p75ECD) 
and intracellular (p75ICD) domains. Schwann cell-derived 
factor induced attenuation of NgR/p75NTR signaling which 
in turn suppressed epidermal growth factor receptor (EGFR) 
activation, thereby potentiating the disinhibition of axonal 
growth.9
Interfering with RhoA is a more comprehensive way to 
overcome inhibitory signals. RhoA is a small GTPase that 
is part of the intracellular signaling pathway through which 
multiple inhibitors cause the collapse of growth cone and 
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arrest axonal growth. Inhibition of RhoA results in modest 
levels of axonal regeneration of injured ON, while blockade 
of Rho-associated coil-forming protein kinase (ROCK) 
promotes the neurite outgrowth of adult RGCs only in the 
presence of growth-promoting factors.10 Bcl-2-associated 
athanogene-1 (BAG1) is an Hsp70/Hsc70-binding protein 
which can suppress apoptosis and enhance neuronal differen-
tiation. Planchamp et al demonstrated that BAG1 induced an 
intracellular translocation of Raf-1 (an enzyme, a member of 
Raf family which belongs to MAP kinase kinase) and ROCK2 
and ROCK activity was decreased in a Raf-1-dependent man-
ner by BAG1’s overexpression. Therefore, BAG1 promotes 
axonal outgrowth and regeneration in vivo via Raf-1 and 
reduction of ROCK activity.11
MAG is involved both in the initiation of myelination 
in the CNS12 and in the events of cell adhesion during ON 
regeneration.13 MAG is necessary for the maintenance of 
the cytoplasmic collar and periaxonal space of myelinated 
fibers.14 Axonal regeneration in the CNS of adult MAG-
deficient mice was not improved when compared to wild-type 
animals,15 but inactivation of MAG enhances ON regenera-
tion. Wong et al used the retina-ON explants of embryonic 
chicks and eliminated MAG function acutely along ON using 
chromophore-assisted laser inactivation (CALI). They found 
that CALI of MAG permitted significant regrowth of retinal 
axons passing the lesion site of the CNS.16
CSPG, a matrix protein that occurs naturally in the CNS, 
is considered to be a major inhibitor of axonal regeneration 
and is known to participate in the activation of the inflam-
matory response. The isolated CSPG has a molecular mass 
of 500–600 kDa and carries the HNK-1 (a glycan that could 
be found in a number of neural cell adhesion molecules) 
carbohydrate epitope.17 CSPG is expressed in the glial 
scar18 and significantly contributes to the nonpermissive 
properties of the CNS environment during axonal regen-
eration. Chondroitin sulfate moieties of the proteoglycans 
were shown to be involved in patterning the early phase 
of axonal growth across the midline and at a later stage 
controlling the axon divergence at the chiasm.19 A study on 
zebrafish also showed that CSPGs contribute to repellent 
axon guidance during regeneration of the optic projec-
tion.20 In adult rats, the microcrush lesion site of the ON 
was CSPG-immunoreactive and an adjacent GFAP-negative 
zone developed early after the lesion. Axons regrew towards 
the lesion, but most of them stopped abruptly at the glial 
scar. CSPG-positive scar and the myelin-derived growth 
inhibitory proteins contribute to the failure of in vivo RGC 
regeneration after injury.21
The Rho/ROCK pathway mediates the inhibitory activity 
of neurite growth associated with CSPGs of the CNS glial 
scar. Concomitant application of chondroitinase ABC and 
ROCK inhibitors may make optic fibers pass over barriers 
in the severely injured ON. Inhibition exerted by CSPGs in 
vitro can be blocked by application of either C3 transferase, 
a specific inhibitor of the Rho GTPase, or Y27632, a specific 
inhibitor of the Rho kinase. RGC axon growth on glial scar 
tissue was enhanced in the presence of C3 transferase and 
Y27632, respectively.22 Suppressing the kinase function of 
the EGFR blocks the activities of both myelin inhibitors and 
CSPGs in inhibiting neurite outgrowth. In addition, regen-
eration inhibitors trigger the phosphorylation of EGFR in a 
calcium-dependent manner. Local administration of EGFR 
inhibitors promotes significant regeneration of injured ON 
fibers, pointing to a promising therapeutic avenue for enhanc-
ing axonal regeneration after CNS injury (for a summary of 
main inhibitors of RGC axon regeneration, Table 1).
The adoptive transfer of T cells specific to proteins 
associated with CNS myelin, such as myelin basic protein, 
can reduce the posttraumatic secondary degeneration of the 
rat ON. The synthetic peptide copolymer 1 (Cop-1), known 
to suppress experimental autoimmune encephalomyelitis, 
can be safely substituted for the natural myelin antigen in 
both passive and active immunizations for neuroprotection 
of the injured ON.23 Protection from glutamate toxicity 
requires reinforcement of the immune system by antigens 
that are different from those associated with myelin. The 
use of Cop-1 apparently circumvents this antigen specificity 
barrier. In the rat ocular hypertension model, immunization 
with Cop-1 significantly reduced the RGC loss without 
affecting the intraocular pressure.24 Vaccination was tried to 
enhance ON regeneration because myelin-derived inhibitors 
Table 1 A summary of main inhibitors of axonal regeneration of 
RGCs and their blockers
Inhibitors Strategies that block the inhibitors
Myelin-derived inhibitors
Nogo-A Anti-Nogo-A antibody or expression of 
a dominant-negative form of the Nogo 
receptor
Nogo receptor RNA interference, interfering with the 
intracellular signaling pathway such as 
Rho/ROCK and SCH vaccination
MAG Chromophore-assisted laser inactivation 
of MAG
A matrix-derived inhibitor
CSPG Chondroitinase ABC
Abbreviations: CSPG, chondroitin sulfate proteoglycan; MAG, myelin-associated 
glycoprotein; RGCs, retinal ganglion cells; ROCK, rho-associated coil-forming 
protein kinase; SCH, spinal cord homogenate.
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were  discovered. Spinal cord homogenate (SCH) contains 
abundant myelins. Enhanced axonal regeneration of RGCs 
was found after ON microcrush in SCH-vaccinated animals. 
In culture, serum from SCH-vaccinated animals promoted 
the neurite growth of RGCs on myelin but not on CSPG.25
Neurotrophic factors
Lack of neurotrophic factors is also a crucial reason for RGC 
death and axonal regeneration in ON injury or diseases. In 
support of RGC survival, neurotrophic supplement is a tra-
ditional and effective strategy.
Several neurotrophic factors such as brain-derived 
neurotrophic factor (BDNF) and neurotrophin-4 or 5 (NT-
4/5) are found to be effective not only for rescuing RGCs 
from retrograde cell death, but also for promoting growth 
of intraretinal axons.26 A single injection of BDNF or the 
prolonged administration of NT-4/5 by mini-pump increases 
the median lengths of axon branches after ON transection in 
adult rats, but neurotrophin-3 (NT-3) does not significantly 
influence axonal regrowth.27 Negishi et al compared the effect 
of grafts combining with trophic factors on ON regenera-
tion in adult rats and found that the degree of regeneration 
was significantly increased by BDNF and NT-4 in the grafts 
and in the vitreous. They showed that neurotrophin recep-
tors (tropomyosin receptor kinase [Trk]-A and Trk-B) were 
detected in nerve fibers in both retina and graft.28 On the 
axonal regeneration by PN transplantation in cats, a combined 
injection of BDNF, CNTF, and forskolin resulted in a 3.4-fold 
increase of beta-RGCs with regenerating axons. Watanabe et 
al suggested that the increase of regenerating beta-RGCs was 
mainly due to the enhanced effect of neurotrophic factors on 
their survival, and possibly to a change of RGC properties by 
cAMP to facilitate their axonal regeneration.29
Inhibition of CNS axon growth is mediated in part by 
calcium-dependent phosphorylation of axonal EGFR. A 
local administration of EGFR kinase inhibitors AG1478 and 
PD168393 to an ON lesion site can promote axonal regen-
eration of adult RGCs. However, Douglas et al showed that 
EGFR was neither constitutively expressed, nor activated 
in the ON axons in non-regenerating and regenerating ON 
injury models. Neurotrophins released by AG1478 stimulated 
disinhibited axonal growth of RGCs in CNS myelin-treated 
cultures by the induction of regulated intramembranous pro-
teolysis of p75(NTR) and Rho inactivation. They attributed 
AG1478-stimulated neuritogenesis to the induced release of 
neurotrophins together with raised cAMP levels in treated 
cultures, leading to axon growth and  disinhibition by 
 neurotrophin-induced regulated intramembranous proteolysis 
of p75(NTR). These off-target effects of EGFR kinase inhibi-
tion suggest a novel therapeutic approach for the regeneration 
of CNS including RGC axons.30
BDNF released from RGCs acts as a survival factor 
for postsynaptic neurons in retinal target fields.31 BDNF 
protects RGCs from apoptosis mediated by transient isch-
emia through inhibition of c-Jun and caspase-2 activities.32 
BDNF concentration dependently improved the survival 
of cultured RGCs, particularly of those small RGCs.33 The 
number of BDNF-positive RGCs increased 2-fold 2 days 
after axotomy, and the percentage of RGCs expressing 
TrkB was elevated by 50%, while the number of TrkA-
positive RGCs doubled after axotomy in comparison to 
the controls.34 Insulin-like growth factor-I, an important 
factor in retinal development, prevents secondary death of 
RGCs after axotomy via phosphoinositide 3-kinase (PI3K)-
dependent protein kinase B (AKT) phosphorylation and 
by inhibition of caspase-3.35 In the mature retina, CNTF 
treatment, via Janus kinase/signal transducers and activators 
of transcription signaling, enhances survival of RGCs and 
photoreceptor cells exposed to otherwise lethal perturba-
tion.36 Adenovirus (ADV)-mediated CNTF expression in rat 
RGCs enhances RGC survival after ON transection.37 The 
protective effect of CNTF may result from activation of its 
high-affinity receptor expressed in RGCs, that switches the 
state of RGCs into more neuroprotective phenotype. CNTF 
also modulates glial cells in the retina and may buffer the 
high concentration of glutamate.38
The ways to supply neurotrophic factors in vivo include 
systemic application, intravitreal injection, and virus-medi-
ated gene transfection. For instance, systemic application 
of glial cell-line-derived neurotrophic factor (GDNF) was 
reported to rescue some RGCs from axotomy. Using elec-
trophoration, GDNF gene transferred into RGCs can increase 
RGC survival 2–4 weeks after ON transection.39 Adminis-
tration of adeno-associated virus (AAV) vector expressing 
CNTF into the eyes protects RGCs undergoing focal injury 
and local ischemia in rats.40 AAV containing basic fibroblast 
growth factor (bFGF) or BDNF is neuroprotective to RGCs 
from excitatory injury caused by N-methyl-d-aspartic acid 
(NMDA) or nerve crush.41
Besides injection of neurotrophic factors and increase 
of gene expression mediated by virus vectors, olfactory 
ensheathing cells (OECs) transplanted into the injured ON 
also increase beneficial neurotrophic factors like BDNF to 
promote RGC survival in rats,42 and an in vitro study demon-
strated that it is BDNF produced by OECs that can enhance 
the survival of injured RGCs.43
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Cui et al compared several neurotrophins including 
BDNF, NT-4/5, FGF, and GDNF, and concluded that CNTF 
is the only effective factor that promotes a long-distance 
axonal regeneration of RGCs, whereas BDNF and NT-4/5 
can only enhance neurite sprouting within the retina.44,45 
To enhance the ON regeneration, neurotrophin synergy is 
required. Logan et al demonstrated that a combination of 
basic FGF, NT-3, and BDNF delivered to the somata of RGCs 
promoted greater neuronal survival and axonal growth than 
each neurotrophic factor alone. They showed that the triple, 
but not single, neurotrophin treatment may decrease 30% 
RhoA activation, and thus increase axonal regeneration.46 
Many approaches promoting ON regrowth are combination 
of neurotrophic factors and other ways such as PN trans-
plantation, lens injury, and chondroitinase application (for a 
summary of main neurotrophic factors, see Table 2).
Factors related to lens injury
Mansour-Robaey et al discovered that an injury on the 
lens secretes unidentified factors which promote neuronal 
survival and axonal regeneration of RGCs.47 Further inves-
tigations showed that such a lens injury also resulted in 
re-innervation of the visual center48 and recovery of visual 
evoked potentials.49
Macrophage activation by lens injury appeared to play a 
key role, because intraocular injections of zymosan, a yeast 
cell wall preparation, stimulated monocytes in the absence of 
the lens injury and induced RGCs to regenerate their axons 
into the distal ON or a PN graft.50 The axonal growth of RGCs 
is also enhanced by delaying macrophage activation for a few 
days after ON transection.51 Oncomodulin is a calcium-binding 
protein secreted intravitreally in combination with cAMP by 
macrophages, and accumulates rapidly in the eye after intravit-
real inflammation and exhibits cAMP-dependent, high-affinity 
binding to a cell surface receptor on RGCs. Oncomodulin 
promotes axonal regeneration of RGCs possibly regulated 
through mammalian sterile 20-like kinase-3b, a homolog of a 
yeast kinase52,53 and is potentiated by both the sugarman-nose 
found in vitreous humor and forskolin-stimulated cAMP eleva-
tion.51,54,55 However, one group observed that neuroprotective 
and axon growth-promoting effects of intraocular inflamma-
tion did not depend on oncomodulin or the presence of large 
numbers of activated macrophages.56
Astrocyte-derived CNTF and leukemia inhibitory fac-
tor are also the major contributors to the neuroprotective 
and axonal growth-promoting effects on mature RGCs 
caused by lens injury and zymosan.57,58 Muller reported that 
astrocyte-derived CNTF activated the STAT/JAK pathway 
and promoted RGC survival and axonal regeneration after 
lens injury.59 Alpha-crystallins of the beta/gamma superfam-
ily are the lens-derived activators of cascades and mimic the 
effects of lens injury, which led to axonal regeneration after 
ON crush in rats.60
Cyclic AMP
The level of cAMP plays a role in modulating outgrowth 
of nervous system. Urbina et al found that cAMP level was 
crucial for retinal outgrowth and regeneration. Forskolin, a 
potential activator of adenylate cyclase system and biosyn-
thesis of cAMP, decreased the outgrowth of post-crushed 
goldfish retina in a dose-dependent manner.61 In the guid-
ance of growth cones of RGCs, cAMP was found involved 
in conversion of netrin-1-induced attraction of growth cones 
to repulsion. Höpker et al reported in Xenopus laminin or 
fragment of laminin that YIGSR converted netrin-1 attraction 
to repulsion of RGC growth cones, and low levels of cAMP 
in growth cones also led to such conversion. Moreover, the 
amount of cAMP decreased in the presence of laminin or 
YIGSR.62 Years later, the same group demonstrated that a low 
level of cAMP developmentally and intrinsically regulated 
the aged axon responsiveness to netrin.63 Another negative 
regulator of RGC growth cone movement, Sonic hedgehog, 
may decrease the level of cAMP in growth cones.64
In the PN-grafted ON stump, a combinational intravit-
real injection of neurotrophins such as BDNF, CNTF, and 
forskolin may increase neuronal survival and axonal regen-
eration of RGCs, and the cAMP elevation by forskolin may 
contribute to the promotion of the RGC regenerative profile.29 
Some small molecules including mannose and glucose were 
proved to have the effect of promoting axonal regeneration of 
RGCs in a cAMP-dependent manner in the higher or lower 
vertebrates.54 High level of cAMP abrogates the ability of 
CNS molecules to inhibit axonal elongation. Using the ON 
crushing model in adult rats, Monsul et al showed that intra-
Table 2 A summary of main neurotrophic factors that enhance 
the neuronal survival and axonal regeneration of RGCs
Neurotrophic factors Effects of the factors
BDNF and NT-4/5 Rescuing RGCs from retrograde cell death 
and promoting growth of intra-retinal axons
CNTF Enhancing survival of RGCs. The only 
effective factor that promotes a long-distance 
axonal regeneration of RGCs
GDNF Rescuing some RGCs
bFGF Protecting RGCs
Abbreviations: BDNF, brain derived neurotrophic factor; bFGF, basic fibroblast 
growth factor; CNTF, ciliary neurotrophic factor; GDNF, glial cell-line-derived 
neurotrophic factor; NT-4/5, neurotrophin-4 or 5; RGCs, retinal ganglion cells.
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ocular injection of cAMP analog  dibutyryl-cAMP promoted 
ON regeneration without increasing RGC survival. Their 
study also proved that cAMP did not enable axons to undergo 
rapid, sustained, and lengthy elongation.65 In the cat ON crush 
model, elevation of intracellular level of cAMP by forskolin 
also promoted axonal regeneration beyond the crush site to 
some extent.66 Another cAMP analog 8-(4-chlorophenylthio)-
cAMP (CPT-cAMP) was unable to promote RGC axons to 
regenerate into the PN graft, but significantly potentiated 
CNTF-induced axonal regeneration. Blockade of cAMP 
pathway did not affect spontaneous RGC survival and regen-
eration but effectively blocked CNTF/CPT-cAMP induced 
survival and regeneration. The CNTF/CPT-cAMP effect was 
proved to be a result of multiple pathways actions, with pro-
tein kinase A (PKA) as an essential component.67 CPT-cAMP 
and PKA inhibitor accelerated and decelerated the rates of 
ON regeneration, respectively, and the inhibitor application 
altered the RGC axon guidance in vitro, suggesting that the 
therapeutic manipulation of cAMP should ensure topography 
and consequently functions.68
X cells, which are essential for acute vision, suffer from 
rapid death after ON transection but can be rescued by 
intravitreal application of neurotrophins accompanied with 
elevation of cAMP.69 Astrocyte-derived CNTF and lens injury 
were proven to switch mature RGCs to a regenerative state 
following inflammation, and the drug potentiating the effect 
of lens injury may increase the intracellular cAMP level, thus 
resulting in strong axonal regeneration in vivo.59 Co-injection 
of CNTF with CPT-cAMP reduced CNTF-induced upregula-
tion of suppressor of cytokine signal (SOCS) in both mRNA 
and protein, suggesting that cytokine-induced regenerative 
responses could be augmented by cyclic nucleotide in another 
way.70 SOCS overexpression may result in an overall reduc-
tion of axonal regrowth or even complete regeneration failure 
of RGC axons.71 The drug that inhibits cyclic nucleotide pho-
phodiesterase was reported to increase RGC survival possibly 
through activating PKA signal.72 Microarray analysis in fish 
found that a member of cAMP-response element-binding 
protein family, activating transcription factor 3, increased 
8-fold 24 hours after ON injury, indicating the mediator of 
ON regeneration gene expression in fish.73
PTEN–mTOR signal
Phosphatase and tensin homolog (PTEN) is a negative 
regulator of the mammalian target of rapamycin (mTOR) 
pathway. Mechanistic studies of axonal growth during 
development and axonal regeneration after injury reveal the 
PTEN-dependent molecular mechanism as a commonality. 
Deletion of PTEN in adult RGCs promoted robust axonal 
regeneration after ON injury. In adult wild-type animals, the 
mTOR signal was suppressed significantly in axotomized 
RGCs and the protein synthesis was inhibited, leading to a 
limited axonal regeneration. By deletion of PTEN or tuberous 
sclerosis protein 1, one of the protein complexes negatively 
regulating mTOR, neuronal survival and axonal regeneration 
of RGCs were significantly enhanced after ON crushed, while 
administration of rapamycin, the mTOR inhibitor, signifi-
cantly neutralized the survival and regeneration of RGCs in 
PTEN deletion. All these findings suggest that mTOR signal 
is sufficient to promote ON regeneration.2
PTEN antagonizes PI3K and catalyzes conversion from 
phosphatidylinositol 3,4,5-trisphosphate (PIP3) to PIP2, 
thus inactivation of PTEN results in PIP3 accumulation and 
activation of AKT which has many downstream effectors and 
is located in the soma and axon terminals of neurons. Those 
PI3K/AKT effectors may cooperate with other pathways to 
promote injured axonal regeneration. Meanwhile, PTEN con-
trols several downstream signals such as 3-phosphorylated 
phosphoinositides, glycogen synthesis kinase, and mTOR, 
which are crucial for axonal growth.
Intriguing questions about PTEN relating to CNS regen-
eration are still open, such as how the pathway is regulated 
during development and after injury, what other possible 
signals work in concert to promote axonal regrowth, and the 
extension of functionality of new connection resulting from 
PTEN manipulation. Studies in answering these questions 
will make important steps to understand the factors underly-
ing CNS regeneration.74
Lithium
Lithium was found to have protective effects on the ner-
vous system. Lithium treatment caused Bcl-2 expression in 
injured RGCs of neonatal mouse retina in a dose-dependent 
manner, and depleting or forcing Bcl-2 expression deleted 
the protective effects of lithium.75 Later on, lithium protec-
tion to RGCs and axons was proved also in adult rats with 
ON crush.76 Lithium and other drugs have been treated as 
pharmaceutical approach to promote ON regeneration in 
animals.77 To obtain further ON regeneration, those authors 
suggested to use lithium together with other drugs, citicoline, 
for instance, that mediate induction of permissive environ-
ment in the adult CNS.
Increasing studies documented more mechanisms of lith-
ium protection to the CNS, including the spinal cord and ON. 
Through Bcl-2 expression, lithium reinforced the promoting 
effect of chondrointinase ABC that digests CSPG, the main 
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ingredient of scar.78 In addition, lithium could activate Wnt or 
beta-catenin signaling to facilitate healing of bone fracture.79 
While wnt signaling is also crucial for retinal development,80 
activation of Wnt signaling by lithium was proved protective 
to RGCs under elevated pressure81 or excitotoxic damage.82
Gene therapy
Besides genes encoding neurotrophins mentioned before, 
anti-apoptosis genes (such as bcl-2, bcl-xL, p35 and caspase 
inhibitors) were efficiently upregulated by ADV transduction, 
human immunodeficiency virus transactivator of transcrip-
tion containing a protein transduction domain, and AAV 
vector into the ON stump or vitreous body. Those genes 
coding apoptotic proteins including BAX, apoptotic protease 
activating factor, and immediate early gene c-Jun can be 
downregulated by small interference RNA. Increasing studies 
documented that the regulations of these genes effectively 
promote the survival and/or viability of injured RGCs. In 
methodology, non-virus vectors are usually safer than virus 
vectors, but non-virus approaches are not sufficient because 
the expression is transient and needs multiple injections. 
Even the expression of ADV-coding genes is transient and 
requires modifying. Many groups reported that AVV provided 
relatively long-term gene transduction of a large proportion 
of adult RGCs.1
When gene-activated matrices (GAM) are placed between 
the proximal and distal stumps of severed rat ONs, DNA is 
retained within the GAM, promoting sustained transgene 
expression in the ON, in the GAM itself, and, more impor-
tantly, in axotomized RGCs. Plasmids that encode bFGF, 
BDNF, and NT-3 promote sustained survival of RGC for 
over 3 months after the initial injury. These findings suggest 
that immobilized DNA implanted into a CNS lesion will be 
delivered by axon terminal uptake and retrograde transport 
to axotomized neurons. GAM may therefore be a useful 
agent for promoting the survival and axonal regeneration 
of sustained neurons. Further optimization of the matrices, 
plasmids, promoters, and genes present in the GAM will 
promote even more survival or, alternatively, axonal regen-
eration remains to be determined.
Cell and tissue transplantation
Tissue engineering develops scaffolds to serve as a bridge 
to guide and help injured nerve grow through the injury site. 
Using a PN graft as a scaffold is also helpful.83 Moreover, 
cell transplantation offers not only source of cells substantial 
to the lost cells caused by injury, but constant sources of 
neurotrophic factors produced by transplanted cells.
As increasing sorts of cells have been discovered and are 
available, it becomes feasible to supply RGC pool with trans-
planted and thereafter differentiated stem cells to replace the 
lost or dying host RGCs. Embryonic stem cells from eye-like 
structure differentiated into RGC-like cells and regenerate a 
new RGC layer after transplanted into the mouse eyes in the 
presence of NMDA.84 Unfortunately, more studies showed 
that stem cells failed to migrate or express the RGC marker 
after transplanted into the eyes, even some of the grafted 
stem cells differentiated and formed synapses with host cells. 
There exist many problems in the replacement of RGCs with 
transplanted cells, including transplant timing, interaction 
between intrinsic factors of RGCs, and the microenviron-
ment of retinas.1 However, many studies indicate that cell 
transplantation-facilitated ON regeneration or repair is not 
attributed to cell replacement but via released neurotrophins 
from grafted cells.85–87
Since scientists noticed the difference in the regenerative 
ability between the central and peripheral nervous systems, 
studies have been set off to explore the possibility of axonal 
regeneration of central neurons when the surrounding micro-
environments were replaced with the PN grafts.
PN transplantation
Tello was the pioneer to transplant PN onto the ON stump to 
induce axonal regeneration in rabbits, though the outcome 
of the ON regeneration was not fully confirmed at his time.88 
Using modern axonal tracing technique, So and Aguayo 
finally demonstrated that transected RGC axons can regrow 
along a PN graft.83 Interestingly, axotomy seems to be the 
prerequisite for the regrowth of RGC axons, for intact RGCs 
would not extent their axon to the PN graft,89 which is consis-
tent with later research that uninjured RGCs do not respond 
to protective neurotrophic factors like BDNF.90
The regrowth of RGC axons in the PN graft is distance-
dependent. The farther the transplantation site of the PN 
graft onto the ON stump is, the less the regrowth of RGC 
axons occurs.91 This phenomenon possibly attributes to the 
longer time for the diffusible trophic factors produced by 
Schwann cells in the PN graft to reach the soma of RGCs. 
Thus, the longer the distance of the remaining ON stump, the 
more difficult for those factors to reach the soma of RGCs 
resulting in a decreasing effect of the PN on regeneration of 
the RGC axons.92 Pre-degeneration was shown to enhance 
the axonal regeneration of RGCs in the PN graft, and the 
number of regenerating RGCs also depends on the time of 
transplantation after injury. You et al reported that the number 
of regenerating RGCs decreased with increased delay time, 
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and pre-degenerated PN grafts overcome this adverse effect 
to some degree in the rats. To obtain the highest number of 
regenerating RGCs, pre-degenerated PN should be grafted 
immediately after ON lesion.93
Bray et al documented in rats that replacement of the ON 
with an autologous PN segment made axotomized RGCs 
regrow axons into a PN graft, and some of the regenerating 
axons can even reach the superior colliculus (SC) with ter-
minals forming synaptic contact with SC neurons.94 PN may 
serve as a bridge which links axotomized RGC to the brain-
stem, pretectum, or SC, and guide regenerating axons to these 
target areas 8–13 months later.95 Recording from the neurons 
in SC showed that normal light field can induce postsynaptic 
potential,96,97 indicating these synapses are functional.
The underlying mechanisms for the enhancement of 
axonal regeneration of axotomized RGCs by PN grafts are as 
follows: 1) the replacement of injured ON with transplanted 
PN grafts deletes the inhibitory factors that exist in ON as 
these inhibitory factors are not presented in the PN grafts; 2) a 
PN graft containing Schwann cells which secrete neurotrophic 
factors that could diffuse to RGC axons. These factors are 
also protective to RGC somata and enhance RGC survival; 
3) Schwann cells would proliferate and form columns after 
injury, and the basement membranes of the Schwann cell tubes 
possess many adhesion molecules such as L1, J1,98 integrins, 
and laminins, which are beneficial to axonal regeneration.
Although the axons of injured RGCs can be induced 
to regenerate along a PN graft, the number of regenerated 
RGCs is limited. Axons of alpha RGCs regrow faster into 
the PN graft than those of other types of RGCs.99 Quantita-
tive studies showed that regenerating axons of RGCs are 
around 1%–10% of total cell population, according to various 
reports using rodents and cats,100 and this number decreased 
over time. To improve the regeneration of RGC axons, many 
modified methods of PN transplantation emerged. One of 
the methods is to reconstruct the PN graft by Schwann cells 
with lentiviral-mediated transfer of CNTF. This modification 
significantly enhanced neuronal survival as well as the axonal 
regrowth of injured RGCs, because the regenerating axons 
were found myelinated.101 Using a PN-to-ON graft model, 
You et al combined gene therapy with pharmacotherapy 
to promote the long-distance regeneration of injured adult 
RGCs. Autologous sciatic nerve was sutured onto the tran-
sected ON and the distal end immediately inserted into con-
tralateral SC. In experimental groups, three bi-cistronic AAV 
vectors encoding CNTF were injected into different regions 
of the grafted eye. Each vector encoded a different fluores-
cent reporter to assess retinotopic order in the  regenerate 
projection. To encourage sprouting/synaptogenesis, after 6 
weeks some AAV–CNTF injected rats received an intravit-
real injection of recombinant BDNF or AAV–BDNF. Four 
months after surgery, cholera toxin B was used to visualize 
regenerate RGC axons. RGC viability and axonal regrowth 
into SC were significantly greater in AAV–CNTF groups. 
In some cases, near the insertion site, regenerate axonal 
density resembled retinal terminal densities seen in normal 
SC. Complex arbors were seen in superficial but not deep SC 
layers and many terminals were immunopositive for presyn-
aptic proteins vGlut2 and SV2. There was improvement in 
visual function via the grafted eye with significantly greater 
pupillary constriction in both AAV-CNTF+BDNF groups. 
In both control and AAV-CNTF+rBDNF groups, the extent 
of light avoidance correlated with the maximal distance of 
axonal penetration into superficial SC. Despite the robust 
regrowth of RGC axons back into the SC, axons originating 
from different parts of the retina were intermixed at the PN 
graft/host SC interface, indicating that there remained a lack 
of order in this extensive regenerate projection.102
Immunoreaction in the RGC axon environment is an 
essential condition for ON regeneration. Following ON 
transaction, there is an increase in the numbers of the total 
and active forms of microglial cells, the phagocytic cells, 
in the ON stump and retina. PN transplantation onto the 
freshly-cut ON stump and application of microglia inhibitor 
minimized the overall regeneration, suggesting an effect of 
microglial phagocytosis on the ON regeneration.103 Macro-
phages, another kind of phagocytic immune cell, also seem 
to play a beneficial role in axonal regeneration of RGCs. 
Lens injury leads to activation of macrophages that produce 
factors to promote the axonal regeneration of RGCs in the 
PN graft after ON injury. Such effect could also be obtained 
by application of Zymosan, a yeast cell wall preparation, 
which stimulates macrophages even better than lens injury. 
None of the secretion of macrophages is positive to enhance 
ON regrowth, some negative factors exist as well. The opti-
mal effect of macrophages might be regulated by timing of 
macrophage activation.51
Another problem of PN transplantation is that autologous 
grafts may exacerbate the PN dysfunction. Cui et al proposed 
chimerical graft which could be derived from donor or host 
freeze-thawed PN and repopulated with cultured Schwann 
cells or OECs. This approach may provide an alternative 
in clinic.104 Allograft could be available in the presence of 
immunosuppressants such as FK506 and cyclosporin-A. In 
the absence of immunosuppressants, a PN allograft induced 
little axonal regrowth of RGCs in the grafts.105
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RGCs could regenerate their injured axons to the PN 
graft, but those regenerating axons extend only few mil-
limeters in the brain. In order to elevate the effectiveness of 
RGC axonal regrowth, many treatments and drugs need to 
be combined in future research.106
Cell transplantation
Cells have been transplanted into the eye to try to replace the 
dead RGCs or other lost cells after ON injury.107 Although 
stem cells were expected to differentiate and migrate to the 
injured site, there has not been any report to show that trans-
plantation of stem cells could meet this demand up to date. 
However, plenty of studies found that transplanted stem cells 
facilitated ON repair and axonal regeneration via secreting 
trophic factors that play neuroprotective roles.108
Umbilical cord mesenchymal stromal cells were neu-
roprotective and promote axonal regeneration after being 
transplanted into the lesion site of the optic tract. An in vitro 
analysis proved that these cells secreted several immunomodu-
latory and neurotrophic factors including TGF beta-1, CNTF, 
NT-3, and BDNF.109 Neural stem and precursor cells derived 
from embryonic rat spinal cord contributed to the survival 
and axons regrowth of RGCs weeks after being transplanted 
into the lesion site of the optic tract in the neonatal rat. These 
cells secreted several neurotrophic factors in vitro but did not 
replace injured neurons as they did not express the marker 
of neural cells after transplantation.85 Research with chicken 
neural tube stem cells indicated that stem cells facilitated 
ON repair because the transplantation stimulated the expres-
sion of matrix metalloproteinase-2 (MMP-2) in the GFAP 
positive astrocytes in the ON. This process is related to the 
degradation of inhibitory CSPGs leading to a more favor-
able microenvironment for axonal regeneration in the distal 
ON.86 In experimental glaucoma study, Johnson et al found 
that mesenchymal stromal cells transplanted into the vitreous 
could significantly increase the RGC survival, while systemic 
transplantation of the same cells was not neuroprotective.110
Oligodendrocytes precursor cells (OPCs) are multipoten-
tial and regarded as stem cells. NG2-expressing OPCs were 
positioned to inhibit axon growth of both developing and 
regenerating neurons.111 However, using the rat glaucoma 
model, it was found that OPCs were protective to RGCs axons 
when they interacted with inflammatory cells.112
Schwann cells are myelinating cells in the PN and play a 
key role in Wallerian degeneration and subsequent regenera-
tion. Therefore, the transplantation of Schwann cells has been 
used to provide a modified environment of ON to enhance 
regeneration.113
Transplants of OECs are able to induce structural regen-
eration of severed axons from CNS neurons and restore neu-
rological functions in rats. OEC transplantation has become 
one of the promising strategies in restoring lost functions of 
injured CNS. Both bulbar and nasal mucosal OECs prolong 
the survival of the explants. Counts of the surviving RGCs, 
identified by beta-III-tubulin immunohistochemistry and by 
their axon trajectory, show that the bulbar cell preparations 
exhibit around twice the potency of those from the mucosa.114 
Moreno-Flores immortalized primary rat OECs using the 
SV40 large T antigen expressed from a constitutive cellular 
promoter, and reported the isolation and characterization of 
clonal lines. Immortalized OECs have been shown to promote 
axonal regeneration of RGCs.115
An in vitro study showed that adult rat OECs were 
effective promoters of the neurite outgrowth of adult RGCs 
in coculture. This study also provided evidence for a con-
tribution of an intracellular calcium signaling mechanism, 
possibly implicating ensheathing cell adhesion molecules in 
promoting neurite outgrowth116
In the first in vivo study of transplanted OEC into dam-
aged ON by Li et al, unpurified GFP-positive OECs were 
obtained, embedded in a matrix of their own production 
and transplanted into a completely transected rat ON. These 
transplanted OECs survived within the ON and were able to 
stimulate and guide the axonal regeneration of cut RGCs for 
up to 10 mm into the distal stump.117 Although the regenerat-
ing axons were ensheathed by the transplanted cells, none of 
the regenerating axons became myelinated by either central 
or peripheral type myelin. They used the same operative pro-
cedure but transplanted Schwann cells instead of OECs. As 
with the OEC transplants, the Schwann cell transplants also 
induced regeneration of the severed RGC axons into the graft 
region. In contrast to the situation with the OEC transplants, 
however, a considerable number of the regenerating axons 
became myelinated by peripheral type myelin produced by the 
transplanted Schwann cells.118 Pastrana et al used microarrays 
to analyze three OEC populations with different capacities to 
promote axonal regeneration in cultured rat retinal neurons 
and identified a number of candidate genes that might play 
a role in promoting adult axonal regeneration, suggesting 
that MMP-2 does participate in adult axonal regeneration 
induced by OECs.119 Hayat et al demonstrated that pretreat-
ment of OECs with pertussis toxin increased the number of 
subsequently cocultured adult RGCs which regrew neurites 
without affecting neuronal survival. The result supports the 
hypothesis that G-protein-regulated calcium signaling plays 
a significant role of OECs to support axonal regeneration of 
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injured CNS.120 Chimeric PN grafts containing adult OECs 
do not promote regeneration of RGCs.104 However, an in 
vitro study showed that adult OECs, but not Schwann cells, 
promoted the long-distance growth of adult RGC neurites.121
A conditioned medium (CM) is the supernatant of culture 
medium in which cells have been cultured for a short period 
of time. The OEC-CM protected PC12 (cell line derived from 
a pheochromocytoma of the rat adrenal medulla) cells from 
Zn2+ insult,122,123 but was unable to protect normal cultured 
hippocampal neurons and RGCs.116,124 Wang demonstrated 
that such OEC-CM protected cultured RGCs from scratch 
insult, and neutralization of BDNF by a BDNF neutralizing 
antibody attenuated such neuroprotection of the medium.43
OEC in co-grafts had minimal impact on the target rec-
ognition of axons. OECs might be an appropriate cell type 
for direct transplantation into injured neuropil when attempt-
ing to stimulate the reconstruction of a specific pathway.125 
Transplanted OECs have a particular potential within CNS 
neuropil because they can support axonal growth and also 
allow correct target innervation.
A mixture of OECs and fibroblasts cultured from the adult 
rat olfactory mucosa was transplanted through a scleral inci-
sion into the retina. Transplanted OECs have been shown to 
be incorporated into the ON head ensheathing RGC axons.126 
OECs transplanted into the ocular stump of transected ON 
had a transient neuroprotective effect on axotomized RGCs. 
OEC transplantation induced the expression of BDNF in the 
ocular ON stump and retina and delayed the death of axoto-
mized RGCs at a certain survival period (for a summary of 
main tissue and cells used for transplantation, Table 3).42
Clinical neurorestorative strategies
Medicine and factors
Vitamin therapy has been suggested for several decades as a 
possible way to slow down the retinal degenerating process, 
but to date, there is no approved pharmacological therapy. The 
nerve growth factor is potential for the optic neuropathy. A 
study evaluated the pharmacokinetics of CNTF delivered by 
an intraocular encapsulated cell technology (ECT) implant in 
patients with retinitis pigmentosa (RP) and geographic atro-
phy. Results revealed that the intraocular ECT implant has a 
favorable pharmacokinetic profile for the treatment of chronic 
retinal degenerative diseases without systemic exposure. The 
researchers found that implants produced CNTF consistently 
over a 2-year period. The calculated half-life of CNTF in the 
vitreous continuously delivered by ECT implants was 51 
months, with CNTF levels statistically equivalent between 
the 6- and 24-month implant periods. CNTF, anti-CNTF 
antibodies, and antibodies to the encapsulated cells were not 
detected in the serum of patients.127
Cell transplantation
Controlled human embryonic stem cell (hESC) differentia-
tion resulted in >99% pure retinal pigment epithelium (RPE). 
Schwartz et al performed two prospective clinical studies to 
study the safety and feasibility of subretinal transplantation 
of hESC-derived RPE in patients with Stargardt’s macular 
dystrophy and dry age-related macular degeneration. Post-
implantation, structural evidence demonstrated that the cells 
had attached and continued to persist for 4 months. There 
was no hyperproliferation, abnormal growth, or immune-
mediated transplant rejection. Best corrected visual acuity 
improved from hand motions to 20/800 in eye of the patient 
with Stargardt’s macular dystrophy, and vision also improved 
in the patient with dry age-related macular degeneration.128
Neuromodulation
The Argus II epiretinal prosthesis has been developed to pro-
vide partial restoration of vision to subjects blinded from outer 
retinal degenerative disease. Safety and efficacy data support 
the development of higher resolution systems that target macu-
lar placement from implant design and surgical perspectives. 
Table 3 A summary of main tissue and cells used for transplantation to enhance neuronal survival and axonal regeneration of RGCs
Tissue and cells used for transplantation Effects
PN graft Developing scaffolds as a bridge to guide injured ON through the lesion site and 
secreting neurotrophic factors to enhance neuronal survival and axonal regeneration of 
axotomized RGCs
Umbilical cord mesenchymal stromal cells Secreting immunomudulatory and neurotrophic factors, thus can protect injured RGCs 
and promote axonal regeneration
Neural stem and precursor cells Secreting neurotrophic factors
Oligodendrocytes precursor cells Protecting RGC axons when interacting with inflammatory cells
Schwann cells Providing a modified environment of ON to enhance axonal regeneration
Olfactory ensheathing cells Secreting neurotrophic and cell adhesion factors, thus can protect injured RGCs and 
induce structural regeneration of severed RGC axons
Abbreviations: ON, optic nerve; PN, peripheral nerve; RGCs, retinal ganglion cells.
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Currently, the device has been implanted in multiple subjects 
with profound RP. Most subjects showed an improvement 
in tasks assessing orientation and mobility, spatial-motor 
localization, and ability of discerning the direction of motion 
of moving stimuli. About one third of subjects experienced 
measurable improvement in visual acuity with the implant.129
In conclusion, from PN transplantation to PTEN-mTOR 
signals and epiretinal prosthesis, researchers have obtained 
much more insight of ON restoration and functional recov-
ery. Due to the complexity of the CNS injury, combinational 
strategies are always the optimal choice, which will facilitate 
the restoration of the optic neuropathy.
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